Option Care Health Inc. (NASDAQ:OPCH) recently announced its preliminary financial projections for the full fiscal year 2025, sending its stock price soaring to near-record levels. The healthcare provider's strong outlook has instilled considerable confidence among investors, highlighting its robust operational performance and strategic growth initiatives. This positive development underscores the company's solid market position and its potential for continued financial success in the coming year.
On Tuesday, Option Care Health's stock extended its upward trajectory, almost reaching its 52-week peak. The market reacted enthusiastically to the company's preliminary net revenue figures for FY25. During intraday trading, the stock climbed as high as $35.47, just shy of its 52-week high of $35.53. Although it pared some gains by the close of the session, it still finished up by an impressive 8.39% at $34.75 per share.
The company's official statement outlined ambitious targets for the fiscal year 2025, anticipating net revenues to fall between $5.645 billion and $5.655 billion. This range represents the upper end of its earlier guidance, which had been set between $5.60 billion and $5.65 billion, demonstrating a clear upward revision based on current performance. Furthermore, Option Care Health expects to report a net income ranging from $59.1 million to $62.4 million.
Additionally, the adjusted diluted earnings per share (EPS) are projected to be between $1.72 and $1.76, an increase from the previously guided range of $1.68 to $1.72. The adjusted EBITDA is also forecasted to reach $469 million to $473 million, with the lower end of this range surpassing the prior guidance of $468 million. These revised figures collectively signal a period of significant financial strength and growth for Option Care Health.
For the fourth quarter alone, Option Care Health anticipates net revenues of $1.46 billion to $1.47 billion, with a net income in the range of $59.1 million to $62.4 million. The diluted EPS for the quarter is estimated to be between $0.37 and $0.39, and the adjusted EBITDA is projected at $123.7 million to $127.7 million. The official results for these periods, along with the full-year 2026 financial guidance, are slated for release next month, providing further clarity on the company's performance and future outlook.
Option Care Health's impressive preliminary results and optimistic financial guidance have positioned it as a strong contender in the healthcare market. The significant increase in revenue and earnings projections highlights the company's effective operational strategies and its ability to capitalize on market opportunities. Investors are keenly awaiting the official results, which are expected to confirm the company's robust financial health and provide further insights into its growth trajectory for the upcoming fiscal year.